Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes.
- Author:
Lixin MA
;
Yuyi WANG
;
Xinxue LI
;
Jianping LIU
- Publication Type:Journal Article
- From:
Journal of Integrative Medicine
2012;10(3):279-92
- CountryChina
- Language:Chinese
-
Abstract:
Randomized controlled trial (RCT) is considered as the gold standard for the efficacy assessment of medicines. With the increasing number of Chinese patent drugs for treatment of type 2 diabetes, the methodology of post-marketing RCTs evaluating the efficacy and specific effect has become more important.
